Jozal Moore

Jozal Moore, M.D., is an Assistant Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester Medical Center (School of Medicine and Dentistry). She specializes in treating hematologic malignancies, including acute leukemias, myelodysplastic neoplasms, myeloproliferative neoplasms, and stem cell transplantation. Dr. Moore is actively involved in clinical research focused on improving outcomes for patients with myeloid malignancies through innovative therapies and understanding bone marrow microenvironment dynamics.

• Education: MD from University of Rochester School of Medicine/Dentistry (2017); completed residency in Internal Medicine at Brown University Medical School (2020) and fellowship in Hematology & Oncology at University of Rochester Medical Center (2023).

Her research integrates CAR-T cell therapy, genetic factors in AML, and tumor lysis syndrome analysis, as evidenced by her publications in journals like Journal of Clinical Oncology and Blood Advances. Dr. Moore's work emphasizes translational approaches to hematologic malignancies and patient-centered care.

• Scientific Awards: John & Carol Bennett Research Award (2022); Segel-Halterman Fellowship for Hematology Scholarship (2021-2022); Award for Exemplary Primary Care (2020); Excellence in Teaching Award (2019).

She has contributed to clinical trials evaluating therapies like brexucabtagene autoleucel and azacitidine/venetoclax combinations, advancing treatment protocols for relapsed/refractory ALL and AML.